Mobile medical devices manufacturer Inotec has appointed Chad Bateman as its new chief executive.

Bateman was most recently vice president and general manager, Europe at wound care and regenerative medicine company Acelity.

Inotec chairman Adrian Parton said: “The board of directors are pleased to announce the appointment of Chad Bateman who will be starting his new role as chief executive of the company in October and we believe that his extensive experience of the wound care market will help the company drive the growth of Inotec’s novel oxygen therapy products on a global basis.”